Vyne Therapeutics Stock Forecast - Simple Moving Average
| VYNE Stock | USD 2.57 0.25 10.78% |
The Simple Moving Average forecasted value of Vyne Therapeutics on the next trading day is expected to be 2.57 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 6.55. Vyne Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Vyne Therapeutics stock prices and determine the direction of Vyne Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Vyne Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Vyne Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Vyne Therapeutics' systematic risk associated with finding meaningful patterns of Vyne Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Vyne Therapeutics to cross-verify your projections. Vyne |
Most investors in Vyne Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Vyne Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Vyne Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
A two period moving average forecast for Vyne Therapeutics is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility. Vyne Therapeutics Simple Moving Average Price Forecast For the 26th of April
Given 90 days horizon, the Simple Moving Average forecasted value of Vyne Therapeutics on the next trading day is expected to be 2.57 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.55.Please note that although there have been many attempts to predict Vyne Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Vyne Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Vyne Therapeutics Stock Forecast Pattern
| Backtest Vyne Therapeutics | Vyne Therapeutics Price Prediction | Buy or Sell Advice |
Vyne Therapeutics Forecasted Value
In the context of forecasting Vyne Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Vyne Therapeutics' downside and upside margins for the forecasting period are 0.03 and 7.30, respectively. We have considered Vyne Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Vyne Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Vyne Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.2924 |
| Bias | Arithmetic mean of the errors | -0.0194 |
| MAD | Mean absolute deviation | 0.1091 |
| MAPE | Mean absolute percentage error | 0.0455 |
| SAE | Sum of the absolute errors | 6.545 |
Predictive Modules for Vyne Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vyne Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Vyne Therapeutics
For every potential investor in Vyne, whether a beginner or expert, Vyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vyne Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vyne. Basic forecasting techniques help filter out the noise by identifying Vyne Therapeutics' price trends.View Vyne Therapeutics Related Equities
| Risk & Return | Correlation |
Vyne Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vyne Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vyne Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Vyne Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Vyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Vyne Therapeutics stock market strength indicators, traders can identify Vyne Therapeutics entry and exit signals to maximize returns.
Vyne Therapeutics Risk Indicators
The analysis of Vyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vyne Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vyne stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.53 | |||
| Semi Deviation | 3.26 | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.67 | |||
| Downside Variance | 13.55 | |||
| Semi Variance | 10.61 | |||
| Expected Short fall | (4.65) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vyne Therapeutics is a strong investment it is important to analyze Vyne Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vyne Therapeutics' future performance. For an informed investment choice regarding Vyne Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Vyne Therapeutics to cross-verify your projections. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Vyne Stock analysis
When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Vyne Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.72) | Revenue Per Share 0.041 | Quarterly Revenue Growth 11.667 | Return On Assets (0.26) | Return On Equity (0.46) |
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.